Study guide
Coats disease and leukocoria assessment
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Coats disease and leukocoria assessment
Key Takeaways Explain This Topic AI
Coats disease causes telangiectasia, exudation and potentially an exudative detachment.
Absent calcification does not exclude retinoblastoma, and childhood leukocoria needs prompt specialist assessment.
Treatment follows exudative stage and visual potential, with attention to traction and complications.
Last updated: October 2026
Coats Disease
Coats disease is a rare, idiopathic, non-hereditary retinal vascular anomaly characterized by progressive aneurysmal dilatations of retinal vessels, telangiectatic capillary malformations, and massive intraretinal and subretinal lipid exudation, ultimately culminating in exudative retinal detachment.
Epidemiology & Demographics
Gender Predilection: Strong male predominance, with approximately 80% to 85% of cases occurring in males (male-to-female ratio ~3:1 to 4:1).
Laterality: Overwhelmingly unilateral (85% to 90%) ; bilateral cases are exceedingly rare and should prompt investigation for underlying systemic or genetic vitreoretinopathies (such as facioscapulohumeral muscular dystrophy [FSHD] or familial exudative vitreoretinopathy [FEVR]).
Age of Onset: Most commonly diagnosed in young children during the first decade of life (peak age 6 to 8 years ). However, a bimodal age distribution exists: an early, aggressive paediatric form, and a milder, indolent presentation diagnosed in young-to-middle-aged adults.
Cellular Pathophysiology & Vascular Malformations
The fundamental pathological defect in Coats disease is primary endothelial cell failure and loss of vascular pericytes within the retinal microvasculature:
Inner Blood-Retinal Barrier Breakdown: Somatic mutations in the NDP gene (Norrie disease protein / norrin) have been identified in some patients. Endothelial tight junctions disassemble, leading to catastrophic breakdown of the inner blood-retinal barrier.
"Lightbulb" Telangiectasias: Capillaries, venules, and arterioles undergo localized ectasia, saccular outpouchings, and fusiform aneurysmal dilatation, creating the characteristic "lightbulb" telangiectatic vessels typically located in the temporal and inferior mid-periphery.
Massive Lipid Exudation: The incompetent, leaky telangiectasias pour plasma constituents, cholesterol, and lipoproteins into the retina. Lipid precipitates into enormous, glistening, yellowish-white mounds in the outer plexiform layer and subretinal space, often gravitating to the fovea to form a massive subfoveal lipid plaque.
Exudative Retinal Detachment: Progressive accumulation of proteinaceous, amber subretinal fluid separates the neurosensory retina from the underlying RPE without any retinal tears or holes (non-rhegmatogenous, bullous serous detachment).
The Critical Differential Diagnosis: Coats Disease vs. Retinoblastoma
Differentiating Coats disease from retinoblastoma is one of the most critical life-and-death diagnostic challenges in paediatric ophthalmology. Both conditions present with leukocoria (white pupillary reflex) or strabismus in young children:
Diagnostic Parameter Coats Disease Retinoblastoma
Biological Nature Benign idiopathic exudative vasculopathy Malignant intraocular neuroblastic tumour ( RB1 gene mutation)
Intraocular calcification Usually absent, but exceptions occur Common, but its absence does not exclude retinoblastoma; use specialist examination, ultrasound and appropriate MRI
Fundus Biomicroscopy Prominent "lightbulb" telangiectasias, aneurysmal beading, and massive yellow lipid mounds Solid, chalky-white or fleshy pink retinal mass; endophytic or exophytic; abnormal tumour vessels
Exudation Characteristics Enormous yellow lipid exudates and cholesterol crystals in clear/amber fluid Clear subretinal fluid; lipid exudation is distinctly absent
Vitreous Findings Clear vitreous; absence of cellular seeds Vitreous seeding (discrete, floating tumour clumps) in endophytic forms
Anterior Segment Clear anterior chamber until late stages; normal iris May show tumour pseudohypopyon, iris nodules, or spontaneous hyphaema
Eye Size (Ultrasonography) Normal axial length for age Normal axial length for age
Caution
A child with uncertain leukocoria requires urgent ocular-oncology assessment. Do not biopsy a suspected retinoblastoma or infer benignity from absent calcium. Imaging and examination guide management; uncertainty alone does not prescribe an automatic enucleation in every eye.
Shields Staging System & Management Paradigms in Coats Disease
The Shields classification provides a rigorous framework for staging and therapeutic intervention:
Stage 1 (Telangiectasia only): Telangiectatic and aneurysmal vessels without intraretinal or subretinal exudation. Managed with direct argon or diode green/yellow laser photocoagulation applied to the telangiectatic vessels to obliterate abnormal flow.
Stage 2 (Telangiectasia and exudation):
Stage 2A: Extrafoveal exudation. Treated with confluent focal laser photocoagulation or transscleral cryotherapy to the abnormal peripheral telangiectatic beds.
Stage 2B: Foveal exudation. The offending peripheral telangiectasias are aggressively ablated. Direct laser to the fovea is strictly avoided ; resorption of subfoveal lipid occurs slowly after vascular leakage is controlled; the interval varies and established foveal damage can persist. Anti-VEGF can be considered selectively as an adjunct, with attention to traction/fibrosis risk; control of abnormal leaking vessels remains central.
Stage 3 (Exudative Retinal Detachment):
Stage 3A: Subtotal exudative detachment (3A1: extrafoveal; 3A2: involving the fovea). Managed with transscleral cryotherapy (double freeze-thaw) to anterior telangiectasias where subretinal fluid prevents laser uptake, with anti-VEGF considered selectively as an adjunct; discuss traction/fibrosis risk and the need to treat leaking vessels.
Stage 3B: Total bullous exudative retinal detachment. Requires surgical intervention: external transscleral subretinal fluid drainage (via sclerotomy) or 23/25-gauge pars plana vitrectomy with internal drainage, endolaser ablation of telangiectasias, and temporary silicone oil tamponade.
Stage 4 (Total detachment with secondary glaucoma): Closed-angle neovascular glaucoma secondary to iris rubeosis or forward displacement of the lens-iris diaphragm. Managed with cyclodestructive procedures (transscleral diode cyclophotocoagulation) or enucleation for blind, painful eyes.
Stage 5 (End-stage): Phthisis bulbi, band keratopathy, cataracts, and complete globe disorganization. Observation or enucleation for intractable pain.